Yen-Chun Liu, M.D., D.Phil.
Dr. Yen-Chun Liu is Assistant Professor of Pathology and Laboratory Medicine at the Weill Cornell Medical College and an Assistant Attending Pathologist at the New York-Presbyterian Hospital (Cornell Campus). She is board certified by the American Board of Pathology in Anatomic Pathology, Hematology and Molecular Genetic Pathology.
Dr. Yen-Chun Liu completed medical school at National Taiwan University in 2002. She subsequently received Master degree in epidemiology from Harvard School of Public Health and Ph.D degree from Johns Hopkins University. She completed residency training in Anatomic Pathology at the National Cancer Institute, National Institutes of Health (2008-2011); followed by a one-year fellowship in Hematopathology (2011, Weill Cornell Medical College) and a fellowship in Molecular Genetic Pathology (2012, Memorial Sloan Kettering Cancer Center). Dr. Liu's clinical responsibilities are concentrated in hematopathology and molecular hematopathology.
Insurance Plans Accepted
The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.
* indicates this physician is no longer accepting new patients with this insurance plan.
- AETNA [HMO]
- AETNA [PPO]
- AETNA [Medicare]
- Aetna - Weill Cornell [POS]
- Affinity Essential
- Affinity Health Plan
- Blue Priority Network
- Emblem Select Care
- Empire Blue Cross/Blue Shield [Pathway X]
- Empire Blue Cross/Blue Shield [Pathway X Enhanced]
- Empire Blue Cross/Blue Shield [PPO]
- Empire Blue Cross/Blue Shield [EPO]
- Empire Blue Cross/Blue Shield [HMO]
- Empire Blue Cross/Blue Shield [Mediblue (Senior)]
- Fidelis Care
- GHI [CBP]
- Health First
- Health Insurance Plan of NY (HIP) [Medicare]
- Health Insurance Plan of NY (HIP)
- Health Insurance Plan of NY (HIP) [Medicaid]
- Health Plus - Amerigroup [CHP]
- Health Plus - Amerigroup
- Health Republic
- Oxford Health Plans [Liberty]
- Oxford Health Plans [Medicare Advantage]
- Oxford Health Plans [Freedom]
- Rockefeller University - CoreSource
- UHC Compass
- United Empire
- United Health Care
- United Health Care [Medicare]
- United Health Care [Community Plan]
- VNSNY CHOICE Medicare [Medicare]
- VNSNY CHOICE Medicare [HMO]
Liu YC, Liu YF, Knowles DM, Orazi A, Tam W. Aberrantly Sustained PAX5 Expression in Plasma Cell Differentiation Is a Frequent Feature in Lymphoplasmacytic Lymphoma but Not Marginal Zone Lymphoma in Bone Marrow. Journal of Hematopathology. 2013 Dec, 6(4):169-177
Aung PP*, Liu YC*, Ballester LY, Robbins PF, Rosenberg SA, Lee CC. Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma. Hum Pathol. 2013 Dec 2. [Epub ahead of print]
Lai JP, Liu YC, Alimchandani M, Liu Q, Aung PP, Matsuda K, Lee CC, Tsokos M, Hewitt S, Rushing EJ, Tamura D, Levens DL, Digiovanna JJ, Fine HA, Patronas N, Khan SG, Kleiner DE, Oberholtzer JC, Quezado MM, Kraemer KH. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D). Acta Neuropathol Commun. 2013 May 8;1(1):4.
Reddi DM, Lu CM, Fedoriw G, Liu YC, Wang FF, Ely S, Boswell EL, Louissaint A, Arcasoy MO, Goodman BK, Wang E. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? Clinicopathological study of 41 cases and correlation of cytogenetic features with treatment regimens. AJCP. 2012 Dec;138(6):855-66.
De Ravin SS, Challipalli M, Anderson V, Shea YR, Marciano B, Hilligoss D, Marquesen M, Decastro R, Liu YC, Sutton DA, Wickes BL, Kammeyer PL, Sigler L, Sullivan K, Kang EM, Malech HL, Holland SM, Zelazny AM. Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis. 2011 Mar 15;52(6):e136-43.
Yustein JT, Liu YC, Gao P, Jie C, Le A, Vuica-Ross M, Chng WJ, Eberhart CG, Bergsagel PL, Dang CV. Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model. PNAS. 2010 Feb 23;107(8):3534-9
Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI, Dang CV. Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS One. 2008 Jul 16;3(7):e2722.
Kim JW, Gao P, Liu YC, Semenza GL, Dang CV. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol. 2007 Nov;27(21):7381-93.
Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer. 2004 Aug 20;111(2):293-7.
- Molecular Hematopathology
- M.D., National Taiwan University School of Medicine (Taiwan), 2002
- M.S., Harvard School of Public Health, 2003
- Ph.D., The Johns Hopkins University, 2009